TY - JOUR
T1 - Cantu Syndrome Is Caused by Mutations in ABCC9
AU - van Bon, Bregje W. M.
AU - Gilissen, Christian
AU - Grange, Dorothy K.
AU - Hennekam, Raoul C. M.
AU - Kayserili, Hülya
AU - Engels, Hartmut
AU - Reutter, Heiko
AU - Ostergaard, John R.
AU - Morava, Eva
AU - Tsiakas, Konstantinos
AU - Isidor, Bertrand
AU - Le Merrer, Martine
AU - Eser, Metin
AU - Wieskamp, Nienke
AU - de Vries, Petra
AU - Steehouwer, Marloes
AU - Veltman, Joris A.
AU - Robertson, Stephen P.
AU - Brunner, Han G.
AU - de Vries, Bert B. A.
AU - Hoischen, Alexander
PY - 2012
Y1 - 2012
N2 - Cantu syndrome is a rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. Using an exome-sequencing approach applied to one proband-parent trio and three unrelated single cases, we identified heterozygous mutations in ABCC9 in all probands. With the inclusion of the remaining cohort of ten individuals with Cantu syndrome, a total of eleven mutations in ABCC9 were found. The de novo occurrence in all six simplex cases in our cohort substantiates the presence of a dominant disease mechanism. All mutations were missense, and several mutations affect Arg1154. This mutation hot spot lies within the second type 1 transmembrane region of this ATP-binding cassette transporter protein, which may suggest an activating mutation. ABCC9 encodes the sulfonylurea receptor (SUR) that forms ATP-sensitive potassium channels (K-ATP channels) originally shown in cardiac, skeletal, and smooth muscle. Previously, loss-of-function mutations in this gene have been associated with idiopathic dilated cardiomyopathy type 10 (CMD10). These findings identify the genetic basis of Cantu syndrome and suggest that this is a new member of the potassium channelopathies
AB - Cantu syndrome is a rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. Using an exome-sequencing approach applied to one proband-parent trio and three unrelated single cases, we identified heterozygous mutations in ABCC9 in all probands. With the inclusion of the remaining cohort of ten individuals with Cantu syndrome, a total of eleven mutations in ABCC9 were found. The de novo occurrence in all six simplex cases in our cohort substantiates the presence of a dominant disease mechanism. All mutations were missense, and several mutations affect Arg1154. This mutation hot spot lies within the second type 1 transmembrane region of this ATP-binding cassette transporter protein, which may suggest an activating mutation. ABCC9 encodes the sulfonylurea receptor (SUR) that forms ATP-sensitive potassium channels (K-ATP channels) originally shown in cardiac, skeletal, and smooth muscle. Previously, loss-of-function mutations in this gene have been associated with idiopathic dilated cardiomyopathy type 10 (CMD10). These findings identify the genetic basis of Cantu syndrome and suggest that this is a new member of the potassium channelopathies
U2 - https://doi.org/10.1016/j.ajhg.2012.04.014
DO - https://doi.org/10.1016/j.ajhg.2012.04.014
M3 - Article
C2 - 22608503
SN - 0002-9297
VL - 90
SP - 1094
EP - 1101
JO - American journal of human genetics
JF - American journal of human genetics
IS - 6
ER -